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Myocardial fibrosis is the common pathophysiologic denominator between myocardial remodeling and the failing heart. Experimental evidence points toward a prominent role of CD4^+^ T helper (Th) lymphocytes, particularly Th17 and Th22 cells, as key players in myocardial remodeling, hence their involvement in humans remains unclear. Quantitative tissue characterization by cardiac magnetic resonance imaging supports noninvasive detection of diffuse myocardial interstitial remodeling by measurement of rates of T1 relaxation.^[@R1]^ We have previously shown that characterization of noninfarcted myocardium by T1 mapping is predictive of outcome in patients with coronary artery disease (CAD), over and above traditional imaging measures.^[@R2]^ We hypothesized that expansion of specific T-cell subsets would be associated with myocardial T1 mapping measurements. Therefore, circulating T cells were measured in forty-six patients with chronic CAD, who were enrolled in the prospective T1 mapping outcome study (NCT03749343). Exclusion criteria were neoplastic/autoimmune/infectious disease, specific nonischemic cardiomyopathies, myocarditis, and immunosuppressive medication. Patients were categorized into 2 groups, based on sequence-specific ranges for native T1 of noninfarcted myocardium^[@R2]^: normal native T1, indicating no remodeling (n=24; median age: 64 \[IQR, 52--68\] years; LVEF (left ventricular function): 58 \[54--62\]%) and abnormal native T1 (n=22; 61 \[52--69\] years; LVEF: 55 \[41--64\]%) as indicative for diffuse interstitial remodeling and fibrosis. Twelve subjects of similar age (57 \[52--66\] years) and sex mix with no known cardiac disease and with normal cardiac magnetic resonance findings served as controls. Blood samples were analyzed for standard cardiac and inflammatory biomarkers. Th-cell subsets were analyzed using multiparameter flow cytometry, and the raw data were subjected to hierarchical cluster analysis as described previously.^[@R3]^ Hierarchical cluster analysis detected a marked expansion of 2 specific Th-cell clusters, phenotypically corresponding to Th22 and Th17 (Figure [1](#F1){ref-type="fig"}B) in patients with diffuse remodeling. We further confirmed a significant increase in Th17 and Th22 cell counts in patients with abnormal T1 signatures (Figure [1](#F1){ref-type="fig"}C). Among patients with CAD, there were no significant relationships between Th-cell subsets and age, sex, CV risk factors, cardiac magnetic resonance cardiac structure or function or the presence of postinfarction scar by late gadolinium enhancement. The latter indicates that expansions of proinflammatory T lymphocytes were indicative for diffuse fibrosis but not for replacement fibrosis.

![**Inflammatory T-cell signatures of cardiac fibrosis.** **A**, Scatter plots of Th-cell clusters (as identified by hierarchical cluster analysis) and (**B**) Uniform Manifold Approximation and Projection dimensionality reduction plots showing expansion of Th17 (CD194^+^CD196^+^CCR10^−^CD183^−^, red cluster) and Th22 (CD194^+^CD196^+^CCR10^+^CD183^−^, green cluster) cells from representative patients with normal (Case 1) and raised (Case 2) native T1. **C**, Absolute Th-cell counts (Kruskal-Wallis H-test followed by Dunn test). CAD indicates coronary artery disease.](res-127-699-g001){#F1}

High-sensitive troponin T (Controls versus CAD normal versus CAD abnormal T1: 4.5 \[3--5.9\] versus 5.9 \[4.5--11\] vs 12 \[6.8--20\] pg/mL; *P*=0.002) and high-sensitivity C-reactive protein (0.09 \[0.05--0.21\] versus 0.08 \[0.05--0.18\] versus 0.22 \[0.09--0.50\] mg/dL; *P*=0.018) were significantly higher in the group with diffuse remodeling, whereas N-terminal pro-brain natriuretic peptide (94 \[39--122\] versus 64 \[32--179\] versus 201 \[79--566\] pg/mL; *P*=0.052) was not significantly different. The groups were similar for total blood leukocyte (*P*=0.18), granulocyte (*P*=0.25), or monocyte (*P*=0.09) counts. In summary, our results indicate that Th17 and Th22 cells may relate to diffuse interstitial remodeling of noninfarcted myocardium in the context of CAD. Despite its novelty, this study is limited by the small sample size and therefore potentially biased by reverse causation and confounding. Future studies are needed to prove the prognostic value of Th17/Th22 polarization, as well as the therapeutic potential of anti-inflammatory treatments to prevent progression of diffuse myocardial remodeling.
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